Inivata Limited
Inivata Limited, a pioneering company in the field of precision medicine, is headquartered in Great Britain (GB) and operates extensively across Europe and North America. Founded in 2014, Inivata has made significant strides in the oncology sector, focusing on the development of innovative liquid biopsy solutions that enhance cancer detection and monitoring. The company’s flagship product, Inivata's InVision platform, stands out for its ability to provide comprehensive genomic profiling through a simple blood test, offering unique insights into tumour dynamics. This technology positions Inivata as a leader in the liquid biopsy market, catering to both clinical and research applications. With a commitment to advancing cancer care, Inivata has achieved notable recognition for its contributions to the industry, solidifying its reputation as a key player in the evolving landscape of personalised medicine.
DitchCarbon Score
How does Inivata Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Inivata Limited's score of 29 is higher than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Inivata Limited, headquartered in Great Britain, currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. The company is a current subsidiary of NeoGenomics Laboratories, Inc., which may influence its climate commitments and reporting practices. As of now, Inivata Limited has not established any documented reduction targets or climate pledges. The absence of specific emissions data and reduction initiatives suggests that the company may still be in the early stages of developing its climate strategy. Given its affiliation with NeoGenomics Laboratories, Inc., emissions data and climate initiatives may be inherited from this parent organization. However, no specific details regarding emissions or targets from NeoGenomics have been provided in the current context. In summary, Inivata Limited is yet to disclose its carbon emissions or set reduction targets, reflecting a potential area for future development in its environmental strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | |
|---|---|
| Scope 1 | 536,000 |
| Scope 2 | 4,181,000 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Inivata Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
